(Q34519166)

2 August 2017

1 reference

title

Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer (English)

1 reference

2 August 2017

1 reference

1 reference

Michael Koutsilieris

1

1 reference

2 August 2017

Constantine Mitsiades

2

1 reference

2 August 2017

Theodoros Dimopoulos

3

1 reference

2 August 2017

John Vacalicos

4

1 reference

2 August 2017

Theocharis Lambou

5

1 reference

2 August 2017

Athanassios Tsintavis

6

1 reference

2 August 2017

Constantine Milathianakis

7

1 reference

2 August 2017

John Bogdanos

8

1 reference

2 August 2017

Dimitrios Karamanolakis

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

11

1 reference

2 August 2017

2

1 reference

2 August 2017

283-293

1 reference

Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis.

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

High dose dexamethasone and base of brain irradiation for hormone refractory metastatic carcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

The role of IL-6 type cytokines and their receptors in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Serum basic fibroblast growth factor in men with and without prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.283

10.1517/13543784.11.2.283

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference